Sinopharm able to provide over 1 bn Covid-19 vaccine doses to rest of world in H2 2021: Chairman

Discarded vials of the Chinese-made Sinopharm Covid-19 vaccine. Credit: AFP Photo

China National Pharmaceutical Group (Sinopharm) has the capacity to provide more than 1 billion Covid-19 vaccine doses to the rest of the world in the second half of this year, the firm's chairman said late on Wednesday.

That level of supply capability assumes vaccination demand in China is being met, Liu said at a panel of the Global Health Forum of the Boao Forum for Asia.